Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

NCT00099320 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00099320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00099320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2004
Completion date
August 31, 2005
Enrollment
182 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus